PHE

CRCE Epidemiology Department

Colin Muirhead, PhD, has led the RPD Epidemiology Section for over 20 years. He studied Mathematics (BSc) and Statistics (MSc and PhD) at Imperial College London, and joined NRPB (now HPA-RPD) in 1983. He has overall responsibility for RPD’s epidemiological studies, has published extensively on radiation risks, and has co-ordinated several multi-national EC contracts in radiation epidemiology, most recently on indoor radon. He is an HPA member of the UK Advisory Groups on both Ionising and Non-ionising Radiation, and has been a member of Committee 1 of the International Commission on Radiological Protection (ICRP) since 1997. He was a consultant to the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) during 1995-2000, and has been a member of the UK delegation to UNSCEAR since 2003. He was a Guest Researcher at the Radiation Epidemiology Branch of the US National Cancer Institute during 1992-93 and during 2001-04 he was a member of the Committee Examining Radiation Risks of Internal Emitters (CERRIE), set up by the UK Government. Under the SOUL contract, he has led HPA’s input to analyses of circulatory disease morbidity and mortality – conducted in conjunction with SUBI – and he is a member of the SOUL Project Management Group. He also co-chairs the International Group on Epidemiology for the Southern Urals. Dr Muirhead was coordinating the SOLO project until 1 August 2010.

Richard Haylock, PhD, is a Medical Statistician and a Leader of the Analytical Epidemiology Group. He joined NRPB in 1991 having gained a BSc in Mathematics and an MSc in Medical Statistics both from Leicester University. At NRPB he began research into the use of Bayesian statistics for estimating computationally expensive functions, which led to a PhD in 1997 from Nottingham University. As a member of the Epidemiology Section he analyses large epidemiological datasets, in particular the National Registry for Radiation Workers, and provides a statistical advisory service to scientists at the HPA. He has experience of collaboration with SUBI under the SOUL contract where he contributed to the analysis of non-cancer data. Dr Haylock is the Scientific Secretary for SOLO.

Svetlana Carr is the Project Administrator for SOLO. She has a Master’s degree in Physics and a Bachelor’s degree in Management. She worked initially as a physicist and then in administration in Ekaterinburg (Russia), prior to moving to the UK in 2004. Her knowledge of Russian should enhance communications between Russian and European beneficiaries.

Staff in the CRCE Business Development Unit (see below) also contributes to management of the contract.

Nezahat Hunter, PhD, is a Medical Statistician. She joined NRPB in 2000, gained her MSc in Statistics at the University of Warwick and PhD in Radiation Epidemiology at the University of Birmingham. Her particular interest is radiation health effects, particularly in the Japanese A-bomb survivors. She is involved in a variety of projects within the HPA’s Radiation Protection Division (formerly NRPB) and has participated in EC contracts on Radon Epidemiology and Alpha-risk projects. She is author and coauthor in numerous publications. Dr Hunter has experience from SOUL of collaborating with SUBI on non-cancer analyses and will continue these activities under SOLO.

Jackie O’Hagan is Leader of the Description Epidemiology Group within the RPD Epidemiology Department. Having joined the former NRPB in 1981, Mrs O’Hagan has worked on the HPA’s epidemiological follow-up studies examining long-term health effects of occupational exposure within the UK’s radiation worker population (NRRW) as well as UK participants in the atmospheric nuclear weapons test programme. She has been a co-author in the resulting publications in national and international peer-reviewed journals. Mrs O’Hagan has experience from SOUL of collaborating with SUBI on quality control checks for data on non-cancer analyses and will continue these activities under SOLO.

Tony Riddell, MPhil, is an internal dosimetry expert with over 24 years of experience of internal dose assessment for both occupational protection and research purposes. He pioneered the use of automated assessment systems to produce the large number of doses needed for plutonium and uranium worker cohort epidemiological studies within the UK. He was also one of the original architects of the Integrated Modules for Bioassay Assessment (IMBA) internal dose assessment system that is now widely used throughout the world. He worked for BNFL for 15 years prior to joining Westlakes Scientific Consulting in 1994 and worked on the Alpha-risk (work package secretary) and SOUL (dosimetry committee co-chair) projects conducted under the EC 6th Framework Programme. He joined HPA in December 2011.

Michael Gillies is a Senior Statistician. Since 1997 Michael has worked on a range of national and international epidemiological studies examining the health effects associated with occupational radiation exposure. Michael has been involved in working on the Alpha-risk and SOUL projects conducted under the EC 6th Framework Programme. He was formerly at Westlakes Scientific Consulting but joined HPA in December 2011.

Les Scott was formerly Head of IT and Programming at Westlakes Sientific Consulting where he worked on Sellafield workforce epidemiology since1981 as an analyst/programmer and was responsibility for the management and provision of dosimetry data for the BNFL epidemiology studies. He joined HPA in December 2011.

 

CRCE Dose Assessments and Radon Department

John Harrison, PhD, CRCE Director, leads the Dose Assessments Department and, from 1 August 2010, is the SOLO Project coordinator. He joined NRPB in 1974, having gained a BSc in Biochemistry at University College, Wales, and PhD in Biochemistry at St. George’s Hospital Medical School, University of London. He is Secretary to ICRP Committee 2 and is a member of the Task Groups on Internal Dosimetry (INDOS), the Human Alimentary Tract (HAT) and Reference Man. He has published extensively in the area of radionuclide biokinetics and dosimetry and effects. He has considerable experience of contract research work including roles as co-ordinator of mulitipartner EC contracts and work package leader. He has collaborated with URCRM and SUBI in research on internal dosimetry under SOUL and it is planned that this collaboration continues under SOLO.

Alan Birchall, PhD, is head of the Biomathematics Group at PHE-RPD, formerly NRPB, where he has worked since the early 1980s. He received an honours degree in Pure Physics from the University of Durham where his PhD research was on ‘Mathematical Solutions to Problems in Radiological Protection involving Air sampling and Biokinetic Modelling’. He has spent two six-month periods attached to the Pacific Northwest Laboratories (PNL) in the USA. Here, he made a significant contribution to the development of the ICRP respiratory tract model (ICRP-66) and developed the first computer program (LUDEP) for implementing it. He has also worked on the development of software (IMBA) for assessing intakes and calculating doses from bioassay data. He is a corresponding member of the ICRP Task Group on Dose calculations (DOCAL) and a member of the European Radiation Dosimetry Group (EURADOS). He has collaborated with SUBI and Westlakes in research on plutonium dosimetry under SOUL and it is planned that this collaboration will continue under SOLO.

Timothy Fell is a member of the Internal Dosimetry and Computation (IDC) Group at PHE-RPD. He has Physics degrees from Salford and Birmingham Universities and was awarded Mathematics degrees by the Open University whilst working at NRPB, the forerunner of RPD. He has practised internal dosimetry since joining NRPB in 1978. During this time he has worked on several aspects of the subject, including the development of biokinetic models, sensitivity and uncertainty analyses, radiation transport calculations and the development of software to compute dose coefficients for workers and members of the public, including the child, fetus and breast-feeding infant. He is a member of the ICRP Committee 2 Task Group on Dose Calculations (DOCAL) and has collaborated with URCRM on the SOUL project, developing Techa specific biokinetic models for the transfer of radiostrontium to the fetus and breast-feeding infant. It is anticipated this cooperation will continue under SOLO.

Matthew Puncher, PhD, is an internal dosimetrist in the Biomathematics and IDC Groups at HPARPD, which he joined in 2002 (then NRPB). During this time he has been actively involved in the development of the internal dosimetry code, IMBA. His research interests include investigating uncertainties on doses, and the application of Bayesian methods to the process of dose reconstruction. More recently, he has been involved in extending the latter in order to calculate uncertainties on lung doses for nuclear workers as part of the EU funded project, Alpha Risk (WP3).

CRCE Radiation Effects Department

Elizabeth Ainsbury, PhD,joined the Cytogenetics and Biomarkers Group in early 2007 and has since been under the tutorage of Mr Alan Edwards, a recently retired member of the group who has over 30 years of experience in radiation biodosimetry and interpretation of cytogenetic data. As a Senior Radiation Protection Scientist, Dr Ainsbury has developed advanced mathematical statistical software for analysis of cytogenetic data, provides statistical advice to cytogenetics laboratories and individuals worldwide and already has a number of peer-reviewed publications in the fields of radiation biodosimetry and related subjects. Both Mr Edwards and (in the latter part of the SOUL project) Dr Ainsbury have collaborated with URCRM, SUBI and the European partners of the SOUL external dosimetry project and these collaborations are planned to continue under the SOLO project.

Jayne Moquet, BA (Hons), is a Principal Radiation Protection Scientist within the RPD Cytogenetics and Biomarkers Group, with over 25 years experience in the field of biological dosimetry. Ms Moquet has trained staff from SUBI and URCRM in the techniques of fluorescent in situ hybridisation (FISH) for retrospective biological dosimetry. Also, Ms Moquet has worked on the SOUL project, scoring FISH translocations and collating data from the laboratories involved, and it is planned that she will undertake similar activities under SOLO

Kai Rothkamm, PhD, leads the Cytogenetics & Biomarkers Group. He studied Physics (MSc) and Biophysics (PhD) at Giessen University (Germany). After a post-doctoral period at Saarland University (Germany) he was group leader at the Gray Cancer Institute, University of Oxford before joining HPA in 2008. He has been involved in previous (RADNA), current (GENEPI-lowRT) and pending EC contract work (MULTIBIODOSE) and is a member of the EURADOS Working Group ‘Retrospective Dosimetry’. His research interests include DNA damage & repair, non-targeted effects of radiation and biomarkers for radiation exposure.

PHE CRCE Business Development Unit

Anne Dempsey is the PHE Business Manager for the Centre for Radiation, Chemical and Environmental Hazards (CRCE, of which RPD is part), with extensive experience of managing operational and project based business activities. She is the business lead for PHE radiation and chemical EC contract work, and is responsible for financial and contractual management of a range of collaborative EC projects coordinated by PHE.

Member Login

SOLO Project Meetings 2010 - 2015

1. 26-29 April 2010: Oxford, UK - hosted by HPA CRCE

2. 12 November 2010: Chelyabinsk, RU - hosted by URCRM

3. 14-17 March 2011: Lyon, FR - hosted by IARC

4. 19-22 September 2011: Chelyabinsk, RU - hosted by SUBI

5. 26-29 March 2012: Rome, IT - hosted by ISS

6. 4-7 March 2013: Brussels, BE - hosted by EC DG R&I

7. 10-13 March 2014: Munich, DE - hosted by HMGU

8. 16-19 February 2015: Oxford, UK  -  hosted by PHE CRCE